LIP
ALT icon

Lighthouse Investment Partners’s Altimmune ALT Stock Holding History

Lighthouse Investment Partners’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-70,923
Closed -$722K – 390
2024
Q1 		$722K Sell
70,923
-328,434
-82% -$3.34M 0.03% 304
2023
Q4 		$4.49M Buy
+399,357
New +$1.67M 0.2% 116
2023
Q1 		– Sell
-19,536
Closed -$321K – 273
2022
Q4 		$321K Buy
+19,536
New +$219K 0.04% 190

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lighthouse Investment Partners's ALT Position: Q2 2024 in Review

Lighthouse Investment Partners sold out of Altimmune (ALT) in Q2 2024, closing a stake of 70,923 shares — an estimated $722K sold.

Lighthouse Investment Partners first reported a position in ALT in Q4 2022 and held it in 3 quarters. The position peaked at $4.49M in Q4 2023. 173 funds tracked by Wall St. Rank hold ALT as of Q2 2024.

  • Lighthouse Investment Partners reported no remaining Altimmune position as of Q2 2024 after selling out during the quarter.
  • Lighthouse Investment Partners sold 70,923 Altimmune shares in Q2 2024, an estimated $722K.
  • Lighthouse Investment Partners first reported a position in Altimmune in Q4 2022 and held it in 3 quarters.
  • Lighthouse Investment Partners's Altimmune position peaked at $4.49M in Q4 2023.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q2 2024.

Based on Lighthouse Investment Partners's 13F filing for Q2 2024, filed 14 Aug 2024.